Jong-Wei Hsu

Jong-Wei Hsu is an experienced biomedical researcher with a comprehensive background in preclinical development, pharmacology, and nutrition consulting. Currently serving as Study Manager/Scientist at Eisai US since November 2020, Jong-Wei Hsu manages in vivo pharmacology studies for antibody-drug conjugate projects, collaborating with multi-functional teams. Concurrently, as a Nutrition/Medicine Consultant with Daiken Biomedical since August 2018, Jong-Wei Hsu provides scientific guidance and experimental design expertise. Previous roles include positions at WuXi AppTec, University of Oxford, National Taiwan University, Cornell University, and the University of Rochester, showcasing a strong focus on in vivo experiments, innovation in cancer treatment models, and expertise in animal sciences. Jong-Wei Hsu holds a PhD and MS in Lab Medicine and Pathology from the University of Rochester, along with MS and BS degrees in Animal Sciences from National Taiwan University and National Chung Hsing University, respectively.